【华润医药(03320.HK):东阿阿胶预期2024年归母净利增至约15亿-16亿元】华润医药(03320.HK)公布,东阿阿胶预期2024年归属于东阿阿胶股东的净利润约15亿-16亿元,上年同期净利润约11.51亿元;扣除非经常性损益后净利润约14亿-15亿元,上年同期净利润约10.83亿元。

金融界
17 Jan
华润医药(03320.HK)公布,东阿阿胶预期2024年归属于东阿阿胶股东的净利润约15亿-16亿元,上年同期净利润约11.51亿元;扣除非经常性损益后净利润约14亿-15亿元,上年同期净利润约10.83亿元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10